NeuroSense Therapeutics Ltd (NASDAQ:NRSN) currently has a daily average trading volume of 233.25K but it saw 4061285 shares traded in last market. With a market cap of 12.27M USD, the company’s current market price of $0.68 came falling about -10.50 while comparing to the previous closing price of $0.76. In past 52 weeks, the stock remained buoying in the range of price level as high as $2.33 and as low as $0.40.
Taking a look at 20-day trading activity of NeuroSense Therapeutics Ltd (NRSN) gives us an average price of $0.8667, while its current price level is -70.82% below from 52-week high level whereas it is 70.00% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.9857 while that of 200 days or SMA-200 reads an average of $1.0961. A closer look into the stock’s movement over the week reveals that its volatility is standing at 16.37% during that period while stretching the period over a month that increases to 18.37%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 34.64 which implies that the stock is in neutral territory.
Over the week, NRSN’s stock price is moving -16.05% down while it is -45.16% when we observe its performance for the past one month. Year-to-date it is -13.38% down and over the past year, the stock is showing a downside performance of -46.03%.
Currently, NeuroSense Therapeutics Ltd’s total number of outstanding shares is 15.38M. Company’s return on equity (ROE) at -602.40%. Stock’s beta reads 1.48. Its return on asset (ROA) is -377.38% on average.
